Silence Therapeutics plc (NASDAQ:SLN) is one of the top gene editing stocks to buy according to hedge funds. The pharmaceutical industry is seeing advancements in gene therapy and editing technologies, such as CRISPR, with increasing investment in cell and gene therapy sectors despite recent challenges.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing